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Validation of the Functioning in Chronic 
Illness Scale (FCIS)
AbStrACt
Diagnosis of deficient areas in the functioning of patient with chronic disease is necessary to undertake 
the adequate therapeutic actions. The aim of the study was to validate a new self-reported questionnaire 
for patients with chronic disease assessing the impact of the disease on the patient, the patient’s impact 
on the disease and the impact of the disease on patient’s attitudes.
Results: The internal consistency of the questionnaire expressed by a-Cronbach coefficient = 0.855, in-
dicates its high reliability and homogeneity. The set of 24 items fulfilled the assumption of factor analysis: 
the determinant of correlation matrix was 0.001, Kaiser-Mayer-Olkin (K-M-O) statistic was 0.843 and the 
Bartlett’ test of sphericity was statistically significant. The factor analysis was conducted using the principal 
component analysis with Varimax rotation. The scale and subscale levels were determined based on the 
percentiles scale.
Conclusion: The validation procedure revealed that FCIS is a reliable and homogeneous tool to measure 
patient’s physical and mental functioning in the chronic illness. The set of items divided into 3 subscales 
allows evaluation of: the impact of the disease on the patient, the patient’s impact on the disease and the 
impact of the disease on the patient’s attitudes. 
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Introduction
Chronic disease affects all aspects of human life. 
The degree of interference is largely dependent on 
the severity of disease symptoms. The impact of the 
disease essentially covers all areas of human function-
ing, including: physical activity, emotional and spiritual 
sphere, and functioning in society [1–5]. The function-
ing limitation of patients with chronic disease results in 
lower self-value perception, deterioration in well-being, 
increase of anxiety and uncertainty about the future 
[6–10]. According to the available literature the influ-
ence of chronic disease on human life has been studied 
so far, assessing various but single aspects, eg quality 
of life, physical and mental functioning, level of disease 
acceptance, self-efficacy or health self-control location 
[11–13]. However, there are no tools to evaluate the 
overall of patient functioning. It seems reasonable to 
create a simple tool to assess the overall functioning 
of the patient in chronic disease. The tool should allow 
the identification of deficient areas in the functioning 
of patient with chronic disease in order to undertake 
the adequate therapeutic actions. The aim of the study 
was to validate a new self-reported questionnaire for 
patients with chronic disease assessing the impact of 
the disease on the patient, the patient’s impact on the 
disease and the impact of the disease on patient’s at-
titudes.
Methods
Study group 
The study group consisted of 366 patients, 
188 (51%) females and 178 (49%) males with coro-
nary artery disease (CAD) treated with percutaneous 
coronary intervention (PCI). The study was conducted 
64
Medical research journal 2018, vol. 3, no. 2
www.journals.viamedica.pl/medical_research_journal
between March and July 2017. The study population 
characteristics is displayed in Tab 1.
The questionnaire consists of 24 questions divided 
into three parts, with a catalogue of 5 answers added 
to each question. Each answer was graded from 1 to 
5 points. 
the Functioning in Chronic Illness 
Scale (FCIS)
Author: Aldona Kubica
Please, refer to each question by choosing (en-
circling) the answer which best reflects your opinion. 
There are no wrong answers – all answers are relevant 
as long as they are true.
Part 1 – The impact of illness on the patient
Patient’s subjective assessment of the impact of 
illness on his / her life.
Maximal score – illness does not affect the patient’s 
functioning
Minimal score – illness severely affects the patient’s 
functioning
1. My physical capacity is similar as prior to the illness.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
2. The illness limits my physical activity.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
3. Despite the illness I consider myself a whole-
some person.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
4. I have been a burden to my family ever since the 
illness began.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
5. Despite the illness I feel OK.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
6. I feel worse than I felt before the illness.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
7. My life is the same as prior to the illness.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
8. My illness limits my social and family contacts.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
Part 2 – The patient’s impact on the illness.
Defining the patients’ opinions on their impact on 
the course of illness.
Maximal score – the patient believes to have signif-
icant impact on the course of illness 
Minimal score – the patient believes to have no 
impact on the course of illness 
1. My illness exclusively results from my neglect.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
2. My illness is not my fault.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
3. I am primarily responsible for my future well- / 
ill-being.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
4. Only doctors are responsible for my future well- / 
ill-being.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
5. Regular medication intake may be beneficial 
my health.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
6. Medications are more likely to be harmful than ben-
eficial.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
7. Regular daily physical activity may be beneficial 
my health.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
8. Due to my illness, I should limit my physical activity 
to minimum and avoid even lightest exercise.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
Part 3 – The impact of illness on patient’s attitude
Defining the patient’s attitude towards new circum-
stances of life.
Table 1. Characteristics of patients
Parametr Category/ value Number  
of patients
Age > 65 189 (51%)
Education Primary
Vocational
Secondary
Higher 
42 (11%)
123 (34%)
149 (41%)
52 (14%)
Place of residence Town/Village
City
104 (28%)
262 (72%)
Economic status Bad
Acceptable
Good
Very good
18 (5%)
73 (20%)
245 (67%)
30 (8%)
Katarzyna Buszko et al., Functioning in Chronic Illness Scale
65www.journals.viamedica.pl/medical_research_journal
Maximal score – the patient holds a very optimistic 
view for the future
Minimal score – the patient holds a very pessimistic 
view for the future
1. My illness made me actively take care of my health.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
2. I feel helpless against my illness.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
3. I believe that my health can improve.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
4. I suppose that my illness will cause a gradual decline 
of my well-being.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
5. I actively think about steps to be undertaken in order 
to avoid a recurrence of my illness.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
6. The thought about my illness scares me.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
7. I maintain positive thinking about the future.
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
8. I feel as if my illness took everything away from me. 
Definetely NOT (1); rather not (2); I do not know (3); 
rather yes (4); definitely YES (5)
Statistical methods
The procedure of validation of the survey was 
carried out firstly on the basis of all 24 questions and 
then on questions belonging to each part separately. 
We assumed the significance of all statistical tests at 
a = 0.05. The Shapiro-Wilk test was used to assess 
the distribution of total score and the scores of each 
part of the survey. To check the internal consistency 
of the questionnaire the a-Cronbach coefficient was 
applied. Factor analysis was performed using principal 
component analysis with Varimax rotation. The Catell 
criterion and Kaiser criterion were  considered  in order 
to determine components of the questionnaire. The factor 
analysis was preceded by checking: the determinant of 
correlation matrix, Kaiser-Mayer-Olkin (K-M-O) statistic 
and the Bartlett’ test of sphericity. The scale and subscale 
levels were determined based on the percentiles scale.
results
According to the Shapiro-Wilk test the distribution 
of total score and the scores of each part of the survey 
were statistically significant (p < 0.001) and we ob-
served left-skewed distribution of the total score with 
kurtosis 0.29 and skewness of -0,5. 
The value of the a-Cronbach coefficient for all 
24 questions was 0.855 indicating that the question-
naire is reliable and homogenous. Apart from that, we 
investigated a-Cronbach coefficient value by removing 
individual questions. The coefficient’s value was even 
higher when three questions (1, 2 and 5) from part 
two were removed. We noted the value of a-Cronbach 
0.86, 0.855, 0.856 respectively. As the a-Cronbach 
coefficient’s value in general was high for whole ques-
tionnaire, we decided not to remove any questions.
The next procedure which we implemented to 
validate the questionnaire was the factor analysis [14]. 
Generally, in case of occurrence of a high value of 
a-Cronbach coefficient (0.855) the factor analysis is 
not required, as the only one component is loaded 
by majority of items. Nonetheless, we made the factor 
analysis. The set of all 24 questions fulfilled the require-
ment of the factor analysis, i.e. value of the determinant 
of the correlation matrix was 0.001, Kaiser-Mayer-Olkin 
(K-M-O) parameter was 0.843 and the Bartlett’ test of 
sphericity was statistically significant. We carried out 
factor analysis by principal component analysis with 
Varimax rotation. We set the components of the ques-
tionnaire using the Catell criterion (based on the scree 
plot presented in the Fig. 1).
We could choice only one component [14–15]. The 
analysis of factor loadings showed that in the majority 
of items only one component is loaded.
Interpretation of FCIS results
The research conducted with the questionnaire 
assumed implementation of a scale to measure the 
strength or level of the investigated aspects. As it was 
mentioned above, there were scores from 1 to 5 as-
signed to each answer. The maximal score was then 
120 points. For each part of the questionnaire, the total 
score for each subscale was 40 points. The score of the 
scale and scores of the subscales showed skewed dis-
tributions (figure 2) and they were statistically significant 
according to results of Shapiro-Wilk test (p < 0.001). 
Thanks to this, we determined the scale levels based 
on percentile scale. The percentiles determined for the 
scale and for the subscales are presented in Tab. 1.
Considering the scores related to the answers given 
by the surveyed persons, we assumed that the score 
below 30 percentile indicates low physical and mental 
functioning, the score between 30 and 70 percentile 
indicates medium physical and mental functioning 
and the score higher than 70 percentile indicates high 
physical and mental functioning. Alternatively, scoring 
less than 79 points for the entire questionnaire indicates 
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Figure 1. Scree plot
Table 1. The scale’s levels of FCSI
Panel A
Score interpretation  
(Part 1 + Part 2 + Part 3)
Score Percentile levels
≤ 78 low level
79–93 medium level
≥ 94 high level
Maximal score – good functioning in the illness 
Minimal score – bad functioning in the illness
 
Panel B
Score interpretation – Part 1: The impact of illness on 
the patient
Score Percentile levels
≤ 23 low level
24–33 medium level
≥ 34 high level
Maximal score – illness does not affect the patient’s functioning 
Minimal score – illness severely affects the patient’s functioning
Panel C
Score interpretation – Part 2: The patient’s impact on 
the illness.
Score Percentile levels
≤ 24 low level
25–29 medium level
≥ 30 high level
Maximal score – the patient believes to have significant impact on the 
course of illness  
Minimal score – the patient believes to have no impact on the course 
of illness
Panel D
Score interpretation – Part 3: The impact of illness on 
patient’s attitude
Score Percentile levels
≤ 27 low level
28–33 medium level
≥ 34 high level
Maximal score – the patient holds a very optimistic view for the future 
Minimal score – the patient holds a very pessimistic view for the future
low functioning, scoring between 79 and 93 points in-
dicates medium functioning and scores over 93 points 
are classified as high functioning. In case of the first 
subscale evaluating the impact of the disease on pa-
tient the scores under 23 points indicate the low level, 
scores between 24 and 33 are allocated to the medium 
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Figure 2. The distribution of the:  total score of the FCIS, the impact of the disease on patient (Part 1), the patient’s impact 
on the disease (Part 2), the disease on the patient’s attitudes (Part 3)
level and scores over 34 points are classified as the 
high level (Tab.  1).  The second subscale describing 
the patient’s impact on the disease, the scores under 
24 points indicate the low level, scores between 25 and 
29 correspond to the medium level and the scores over 
30 points indicate high level (Tab. 1). The impact of the 
disease on the patient’s attitudes is evaluated in the 
third subscale. In this case 27 points indicate low level, 
scores between 28 and 33 points present medium level 
and scores over 33 points indicate high level. The dis-
tribution of total score and the scores of the subscales 
of FCIS are presented in Fig. 2.
Discussion
The authors of the study conducted a validation pro-
cedure for the Functioning in the Chronic Illness Scale 
(FCIS), a simple self-related questionnaire developed 
by A. Kubica. According to our knowledge FCIS is the 
first tool allowing the comprehensive assessment of 
physical and mental functioning dedicated for patients 
with chronic diseases.
The previously used tools (eg. WHO-DAS II scale) to 
assess physical and mental functioning were developed 
for people with disabilities. However, despite this, the 
WHO-DAS II scale was also applied in chronically ill 
patients with low back pain [16–17]. The CIA question-
naire is another tool for assessment of psychosocial 
functioning in patients with nutrition disorders [18–19]. 
Use of such tools for functioning evaluation of patients 
with chronic illness seems to be inappropriate, as origi-
nally these questionnaires were created to diagnose 
functioning in very specific situations. 
The FCIS consisting of 24 items is characterized 
by a high level of reliability was shown to have a high 
reliability and the homogeneity (Cronbach’s alpha 
coefficient = 0.855). The FCIS was divided into three 
subscales evaluating: the impact of the disease on the 
patient, the patient’s impact on the disease and the 
impact of the disease on the patient’s attitudes. 
The first part of the questionnaire – the subscale 
evaluating the impact of the disease on patient is charac-
terized by a high reliability (Cronbach’s Alpha = 0.841). 
It mainly refers to the patient’s physical efficiency, 
quality of life and acceptance of the disease. These 
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aspects of functioning of patients with chronic illness 
were evaluated in several studies [20–21]. Carson et al. 
[20] showed a relationship between the severity of heart 
failure symptoms according to the NYHA classification 
and the quality of life of patients assessed using the 
MLHFQ questionnaire, while Juenger et al. [21] applied 
the SF-36v2 questionnaire for the same purpose. The 
influence of chronic diseases on the disease accept-
ance was evaluated using the AIS questionnaire and on 
the quality of life using the WHOQoL questionnaire in 
subjects with respiratory diseases [22] and permanent 
atrial fibrillation [23] or using the SF-36v2 questionnaire 
in patients with diabetic neuropathy [24]. The first part of 
the FCIS evaluates also the functioning in terms of physi-
cal efficiency, which is currently widely investigated 
using the ADL scale in both patients [25] and healthy 
subjects [26]. To assess physical efficiency in people 
with chronic diseases, the EuroQol EQ-5D scale was 
proposed, which apart from the physical aspect evalu-
ates the patient’s well-being [27]. The ILQ questionnaire 
was used by Oris et al. [28] for the assessment of impact 
of chronic disease on patients’ lifestyle including some 
physical and mental aspects.
The second and third subscales of the FCIS (char-
acterized by Cronbach’s alpha coefficients of 0.569 and 
0.744 respectively) assessing the patient’s impact on 
the disease and the impact of the disease on patient’s 
attitudes refer mainly to the study of self-efficacy and 
the location of health control. The MHLC questionnaire, 
a commonly accepted tool for examining the location 
of health control, is often used together with question-
naires for the quality of life assessment in chronically 
ill patients. Sengul et al. [29] used the MHLC ques-
tionnaire with the WHOQoL questionnaire to examine 
patients with chronic low back pain, Wielenga - Boiten 
[30] in people with post-traumatic brain injury, and 
Basińska [13] in subjects with Hashimoto’s disease. 
The GSES questionnaire is a tool for assessing one’s 
self-effectiveness. In the study published by Cramm et 
al. [31], this questionnaire was used to assess young 
people with chronic illness. Maeda [32] used this tool 
in patients with heart failure together with evaluation of 
adherence to treatment. The PAM-13 questionnaire was 
also applied to measure the patient’s activity in terms 
of self-efficacy and the location of health control [33].
This questionnaire is characterized by a high Cron-
bach’s alpha in chronically ill patients: 0.870 in the 
Norwegian study by Moljord et al. [33] and 0.860 in the 
study carried out in Singapore by Ngooi et al. [34]. Ry-
dlewska et al. [35] and Siennicka et al. [36] conducted 
researches in patients with chronic illness with simulta-
neous assessment of the location of health control and 
self-efficacy with separate tools. 
 Numerous studies indicate the need for the com-
bined use of various tools for the overall assessment 
of various aspects of the functioning of subjects with 
chronic disease. Therefore, we assumed that there is 
a urgent need for one tool allowing for comprehensive 
and practically useful evaluation of such patients. The 
FICS is a response to this demand. It allows the ex-
amination of patients in various aspects of functioning 
with chronic disease in a quick and simple way, without 
use of several different tools. Such an approach should 
allow to diagnose deficit areas in patients and to imple-
ment appropriate interventions by the members of the 
therapeutic team. The functioning of patients with chron-
ic disease is closely related to medication adherence 
and has a strong impact on clinical outcome [37–42] .
Conclusion 
The validation procedure revealed that FCIS is a reli-
able and homogeneous tool to measure patient’s physi-
cal and mental functioning in the chronic illness. The set 
of items divided into 3 subscales allows evaluation of: 
the impact of the disease on the patient, the patient’s 
impact on the disease and the impact of the disease 
on the patient’s attitudes. 
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